Insulet (PODD) Accounts Payables (2010 - 2026)
Insulet's (PODD) quarterly Accounts Payables came in at $123.3 million in Q2 2026, up 28.3% on a YoY basis from $96.1 million in Q2 2025, and down 17.69% quarter-over-quarter from $149.8 million in Q1 2026.
Analysis
Insulet (PODD) Accounts Payables (2010 - 2026) Analysis & Trends
Insulet (PODD) has reported Accounts Payables for 17 consecutive years, with $123.3 million the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Accounts Payables rose 28.3% year-over-year to $123.3 million; the trailing twelve-month figure through Jun 2026 stood at $123.3 million (up 28.3% YoY), and the FY2025 full-year result was $75.0 million, up 278.79% from the prior year.
- Accounts Payables fell to $123.3 million in Q2 2026 per PODD's latest filing, from $149.8 million in the prior quarter.
- Across five years, Accounts Payables topped out at $149.8 million in Q1 2026 and bottomed at $19.2 million in Q4 2023.
- Historically, Accounts Payables has averaged $69.8 million across 5 years, with a median of $68.6 million in 2022.
- The sharpest annual moves came in 2024 and 2025: Accounts Payables tumbled 48.2% in 2024, then soared 278.79% in 2025.
- Over 5 years, Accounts Payables stood at $30.8 million in 2022, then slumped by 37.66% to $19.2 million in 2023, then grew by 3.12% to $19.8 million in 2024, then jumped by 278.79% to $75.0 million in 2025, then jumped by 64.4% to $123.3 million in 2026.
- According to Business Quant data, Accounts Payables over the past three periods registered $123.3 million, $149.8 million, and $75.0 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Accounts Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 180.76 Bn | 175.16 Bn | 7.27 Bn | 4.79 Bn |
| 2 | Intuitive Surgical | 127.77 Bn | 122.55 Bn | 1.96 Bn | 277.20 Mn |
| 3 | Medtronic | 117.20 Bn | 108.39 Bn | 6.34 Bn | 2.70 Bn |
| 4 | Stryker | 104.01 Bn | 100.53 Bn | 4.50 Bn | 1.66 Bn |
| 5 | Boston Scientific | 63.51 Bn | 62.97 Bn | 3.85 Bn | 1.23 Bn |
| 6 | Edwards Lifesciences | 49.80 Bn | 45.55 Bn | 1.35 Bn | 210.50 Mn |
| 7 | Alcon | 33.03 Bn | 31.58 Bn | 1.68 Bn | 968.00 Mn |
| 8 | Dexcom | 32.18 Bn | 30.23 Bn | 830.00 Mn | - |
| 9 | Steris | 20.71 Bn | 20.23 Bn | 684.20 Mn | 344.10 Mn |
| 10 | Insulet | 9.35 Bn | 8.82 Bn | 562.60 Mn | 123.30 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 123.30 Mn |
| Mar 31, 2026 | 149.80 Mn |
| Dec 31, 2025 | 75.00 Mn |
| Sep 30, 2025 | 48.20 Mn |
| Jun 30, 2025 | 96.10 Mn |
| Mar 31, 2025 | 57.60 Mn |
| Dec 31, 2024 | 19.80 Mn |
| Sep 30, 2024 | 40.30 Mn |
| Jun 30, 2024 | 76.80 Mn |
| Mar 31, 2024 | 75.90 Mn |
| Dec 31, 2023 | 19.20 Mn |
| Sep 30, 2023 | 77.80 Mn |
| Jun 30, 2023 | 107.50 Mn |
| Mar 31, 2023 | 85.90 Mn |
| Dec 31, 2022 | 30.80 Mn |
| Sep 30, 2022 | 62.10 Mn |
| Jun 30, 2022 | 57.20 Mn |
| Mar 31, 2022 | 52.20 Mn |
| Dec 31, 2021 | 37.70 Mn |
| Sep 30, 2021 | 58.00 Mn |